StockData
Cellectar Biosciences, Inc. logo

Cellectar Biosciences, Inc. (CLRB) stock

CLRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$1.01−0.13 (-11.40%)

Close on Nov 16, 2026Market cap $9.55MP/E –Yield –

Cellectar Biosciences profit margin

Profit margin (net margin) is net income as a percentage of revenue.

No profit margin figures for Cellectar Biosciences

Cellectar Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Cellectar Biosciences figures

See a number that looks wrong?